| 000 | 01851 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517165255.0 | ||
| 264 | 0 | _c20180607 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-017-4416-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlkner, S | |
| 245 | 0 | 0 |
_aPrognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cNov 2017 |
||
| 300 |
_a481-490 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLetrozole |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 |
_aNitriles _xadministration & dosage |
| 650 | 0 | 4 |
_aNuclear Receptor Coactivator 3 _xmetabolism |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 |
_aTissue Array Analysis _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aJensen, M-B | |
| 700 | 1 | _aRasmussen, B B | |
| 700 | 1 | _aBendahl, P-O | |
| 700 | 1 | _aFernö, M | |
| 700 | 1 | _aRydén, L | |
| 700 | 1 | _aMouridsen, H | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 166 _gno. 2 _gp. 481-490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-017-4416-0 _zAvailable from publisher's website |
| 999 |
_c27424475 _d27424475 |
||